Last Updated 2 December 2022.
2 Vaccines Approved for Use in Hong Kong
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
42 trials in 10 countries
Approval Source: reuters.com
6 Vaccines in Clinical Trials in Hong Kong
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
73 trials in 34 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
42 trials in 10 countries
-
Sinovac Biotech (Hong Kong) Limited
COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 1 country
-
The University of Hong Kong
SARS-CoV-2 DNA Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
The University of Hong Kong
DelNS1-nCoV-RBD LAIV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country